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Abstract
Background: Chest pain is one of the most common complaints in the Emergency Department
(ED), but the cost of ED chest pain patients is unclear. The aim of this study was to describe the
direct hospital costs for unselected chest pain patients attending the emergency department (ED).
Methods: 1,000 consecutive ED visits of patients with chest pain were retrospectively included.
Costs directly following the ED visit were retrieved from the hospital economy system.
Results: The mean cost per patient visit was 26.8 thousand Swedish kronar (kSEK) (median 7.2
kSEK), with admission time accounting for 73% of all costs. Mean cost for patients discharged from
the ED was 1.4 kSEK (median 1.3 kSEK), and for patients without ACS admitted 1 day or less 7.6
kSEK (median 6.9 kSEK). The practice in the present study to admit 67% of the patients, of whom
only 31% proved to have ACS, was estimated to give a cost per additional life-year saved by hospital
admission, compared to theoretical strategy of discharging all patients home, of about 350 kSEK
(39 kEUR or 42 kUSD).
Conclusion: Costs for chest pain patients are large and primarily due to admission time. The
present admission practice seems to be cost-effective, but the substantial overadmission indicates
that better ED diagnostics and triage could decrease costs considerably.
Background
Patients attending the emergency department (ED) with
chest pain indicating a possible acute coronary syndrome
(ACS) are very common. In Sweden (population 9 mil-
lion), some 180,000 patients with suspected ACS present
to EDs every year [1]. Treatment of ACS has improved dra-
matically over the last two decades, but it has also become
time-dependent, and the prognosis of the patient now
depends on accurate management decisions made already
at the ED. In addition, the therapy for ACS has become
costly, with new drugs and balloon angioplasty using
advanced stents.
Because of the costly therapy and the large size of the
patient category, correct management decisions in the ED
are probably also of great economic importance. Though
there are numerous studies describing costs for subgroups
of chest pain patients [2-10], there are few data regarding
the economic consequences of ED decisions in an unse-
lected chest pain patient population [11]. With such data
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available, it seems reasonable that hospital resources
could be better allocated to and within this large patient
group, and that more rational development of chest pain
management programs would be possible.
The aim of this study was to describe the direct hospital
costs for unselected chest pain patients who attend the
ED, focusing on the economic consequences of the deci-
sions by the ED physician to hospitalize the patient, and
to refer the patient to different diagnostic procedures and
levels of in-hospital care. An additional aim was to esti-
mate the cost per additional life-year saved by hospital
admission, compared to theoretical strategy of discharg-
ing all patients home.
Methods
Subjects
The study retrospectively included 1000 consecutive
patients with chest pain attending the ED at Lund Univer-
sity Hospital, Sweden, from July 1 to November 20, 1997.
Lund University Hospital is a 1200 bed institution with
fully public financing that serves a population of some
250,000. The ED has about 47000 visits a year. Percutane-
ous coronary intervention (PCI) and coronary bypass sur-
gery (CABG) are available 24 hours/day. During the
patient inclusion period, there was no systematic diagnos-
tic protocol for patients with suspected ACS, no dedicated
chest pain unit, and no formal strategy for admitting ED
patients to in-hospital care.
Data collection
Using the computerized ED information system, consecu-
tive patients with a presenting complaint of chest pain or
discomfort (e.g. tightness, pressure, "angina") as noted by
the initial triage nurse, were retrospectively included in
the study. Patient data were collected from the medical
records by an experienced research nurse. The discharge
diagnoses were made by the attending senior ward physi-
cians, and also reviewed by a senior research nurse. A
patient was considered having ACS when discharged with
a diagnosis of either AMI or unstable angina. AMI was
defined by the WHO criteria [12] where the biochemical
criterion was at least one measurement of CK-MB>10 µg/
l or Troponin T>0,1 µg/l. The criteria for unstable angina
were: 1) Ischemic symptoms (chest pain >15 min., syn-
cope, acute heart failure or pulmonary oedema) with one
of the following: 2) electrocardiogram (ECG) changes:
transient or persisting ST segment depression (≥ 1 mm)
and/or T-wave inversion (≥ 1 mm) without developing Q
waves or loss of R wave height, 3) Biochemical markers
CK-MB 5 – 10 µg/l or Troponin T 0.05 – 0.1 µg/l.
Only costs following directly from each ED visit until hos-
pital discharge were included. All costs were taken from
the hospital's computerized economy system METIS. All
unit costs were set by the Lund University Hospital econ-
omy department and were the yearly calculated average
unit costs. The unit cost for the ED visit and the cost per
admission day at the respective wards include overheads,
capital costs, staff costs and pharmaceutical costs. The
total cost for each included patient was calculated as the
sum of the cost of the ED and hospital admission (when
applicable) and the costs of performed procedures and
diagnostic tests (laboratory tests, x-ray, exercise test etc.).
All costs are from 1997 (no up-rating for inflation) and
are presented in kSEK. In December 2005, 1 SEK equalled
0.11 EUR and 0.12 USD.
Assumptions
In order to evaluate the cost-effectiveness of our current
practice, we made an attempt to estimate the cost of addi-
tional life-years saved with the current admission practice
compared to a theoretical strategy of discharging all
patients from the ED. Using results from the Multicenter
Chest pain study [13] the excess mortality after an ACS
were estimated to be 4.9%, 3.6%, 1.6% for patients 1, 2
and 3 or more years after discharge, respectively [2]. This
increased yearly mortality was applied to a Swedish life
table from 1999 [14] and the life-years lost for each
patients with ACS who died in the present material were
calculated. Previous studies suggest that failure to admit
patients with myocardial infarction [15,16] or unstable
angina [16], increases short term mortality about two-
fold. Thus mortality from ACS was assumed to have
approximately doubled with the theoretical discharge-all
strategy, as has been assumed in previous studies [3,17].
The gain from the actual admission practice compared to
a discharge-all strategy, i.e. additional life-years saved, was
thus estimated to equal the calculated life-years lost with
the actual admission practice. It should be noted, how-
ever, that this assumption does not include potential ben-
efits from PCI therapy to patients with ST-elevation AMI.
Ethical approval and statistics
The Research Ethics Committee at Lund University
approved the study. Data was analysed using the SPSS
12.01 statistical software package. Data are presented as
mean and median. For statistical comparison of means,
the t-test was used when comparing two groups and the
ANOVA test were used when comparing multiple groups.
Differences were considered significant at P < 0.05.
Results
Patient characteristics and overall cost
Selected patient characteristics are presented in Table 1.
813 patients had only one visit and 68 patients had two
visits or more.
The total cost for all patient visits was 26.8 million (M)
SEK. The mean cost per visit was thus 26.8 kSEK (k2.9BMC Emergency Medicine 2006, 6:6 http://www.biomedcentral.com/1471-227X/6/6
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EUR or k3.2 USD), with a median cost of 7.2 kSEK. Fifty-
eight percent of the cases cost less than 10 kSEK, and only
1.3% of the patient visits cost more than 250 kSEK. In
Table 2 is presented a selection of used in-hospital
resources, and in Table 3 is a selection of unit costs pre-
sented.
The decision to discharge or admit
One of the primary decisions to be made by the ED phy-
sician is whether to admit the patient to in-hospital care
or not. A total of 661 patients were hospitalized, and the
length of stay varied from 1 to 143 days with a mean of 5.3
days (median 2 days). As can be seen in Figure 1, left bar,
the decision to admit is usually an economically impor-
tant one; Admission days accounted for 73% and diagnos-
tic procedures (different tests and x-ray) for only 13% of
the total costs.
In chest pain patients perceived to have a low risk of ACS,
the ED physician has the option either to immediately dis-
charge the patient from the ED or to admit the patient for
an in-hospital "ACS rule-out" observation. The latter was
common in the present study, since an ACS was diag-
nosed in only 207 (31%) of the admitted patients. Four
hundred fifty-four patients without a final ACS diagnosis
were admitted, and 244 of these patients (54%) were dis-
charged after one day or less. The distribution of costs for
these patients are shown in Figure 1, right bar. The mean
total cost was 7.6 kSEK (median 6.9 kSEK), with admis-
sion time accounting for 66% and diagnostic procedures
(different tests and x-ray) for 22% of these costs. Patients
discharged from the ED cost a mean 1.4 kSEK (median 1.3
kSEK). For the patients without ACS, the difference
between the mean costs of a "rule-out" observation and
immediate discharge was thus 6.2 kSEK.
Costs in relation to level of care
When the decision has been made to admit the patient,
the next question is bed assignment. Total costs for
patients assigned to different levels of care are presented
in Figure 2. The proportions of patients discharged with a
diagnosis of ACS were for the Coronary Care Unit (CCU),
Intermediate Care Ward (ICW) and General Ward (GW)
60%, 23% and 5%, respectively. Costs for diagnostic pro-
cedures were significantly higher in the CCU (mean 7.8
kSEK, median 3.4 kSEK) than in the ICW (mean 3.6 kSEK)
or GW (mean 4.1 kSEK).
Costs in relation to discharge diagnosis
Patients with ACS (n = 207) as expected generated signif-
icantly higher costs (mean 79.9, median 56.5 kSEK) than
those without ACS (n = 791; mean 12.8, median 6.4
kSEK). Patients with ACS accounted for 62% of the total
cost for all the included patients. Patients with AMI cost a
mean 84,4 kSEK (median 59,2 kSEK).
Cost per life-year saved
The in-hospital mortality for patients with ACS was 5.3%
(11 patients of which two died in the ED) and the total
life-years lost were estimated to be 77 years. Assuming a
Table 3: Examples of unit costs in kSEK, and in corresponding 
EUR.
Costs
kSEK kEUR
Visit at the ED 0.9 0.1
CCU (per day) 10.6 1.2
ICW (per day) 4.6 0.5
GW (per day) 2.6 0.3
CABG 103 11.3
PCI with/without stent 35.3/24.2 3.9/2.7
Coronary angiography 30 . 3
Exercise test 1.1 0.1
Echocardiography 1.1 0.1
ED, Emergency department; CCU, Cardiac care unit; ICW, 
Intermediate care ward; GW, general ward; CABG, coronary artery 
bypass grafting; PCI, percutaneous coronary intervention
Table 1: Characteristics of the chest pain patients included in the 
present study with a total of 1,000 ED visits. CABG, coronary 
artery bypass grafting; PCI, percutaneous coronary intervention
All patients (n = 881)
Median age (percentile 05–95) 65 (31–87)
Male 57%
Smoking 22%
Hypertension 31%
Diabetes 11%
Congestive heart failure 15%
Previous angina pectoris 38%
Previous myocardial infarction 28%
Previous PCI 6%
Previous CABG 10%
Table 2: Examples of in-hospital resource use.
Number per 1000 ED visits
Admitted to CCU 190
Admitted to ICW 408
Admitted to GW 63
CABG 15
PCI 27
Coronary angiography 48
Thrombolysis 41
Exercise test 90
Echocardiography 153
CCU, Cardiac care unit; ICW, Intermediate care ward; GW, general 
ward; CABG, coronary artery bypass grafting; PCI, percutaneous 
coronary interventionBMC Emergency Medicine 2006, 6:6 http://www.biomedcentral.com/1471-227X/6/6
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two-fold increase in mortality and life-years lost if no
patients would have been admitted, the cost of one addi-
tional life-year saved with the current hospitalization
practice, compared to dismissing all patients from the ED,
was estimated to be some 350 kSEK (39 kEUR or 42
kUSD)
Discussion
Since chest pain is one of the most common complaints
in the ED, the cost of these patients has a significant
impact on total health care costs. The present study indi-
cates that costs for chest pain patients are large and prima-
rily due to admission time. Extrapolation of the present
average per-visit cost of 26.8 kSEK yields a cost of 275
MSEK per million inhabitants and year for the evaluation
of patients presenting at the ED with chest pain. Since
there has been a general cost increase about 30% at Lund
University Hospital from 1997 to 2005, we estimate the
current cost to be approximately 360 MSEK per million
inhabitants. In addition to the general cost increase at our
hospital, a number of changes in chest pain management
since 1997 have likely affected cost development. First,
there may have been an increase in hospitalization of low
risk chest pain patients since 1997 [18], which can con-
tribute to a total cost increase. Second and more impor-
tantly, there has been an increased use of coronary
angiography and PCI, and a decreased use of thromboly-
sis [19]. The Swedish national register for coronary care
units (RIKS-HIA) shows an unchanged rate of reperfusion
therapy for ST-elevation myocardial infarction (STEMI)
patients from 1997 to 2003, but a overall nation-wide
increase in the use of primary PCI from about 5% to 20
%[20]. In 2003, Swedish academic medical centres with
revascularization facilities (like our institution) per-
formed primary PCI in more than 50% of STEMI patients
[20]. For non-STEMI patients, inpatient coronary angiog-
raphy increased from 25% to 62% during 1997 – 2003.
This increased proportion of costly invasive procedures
has thus probably increased the total hospital cost of chest
pain patients since 1997. However, the more frequent use
of invasive procedures applies almost only to the minority
of patients that have ACS (21% in the present material),
whereas the management of the majority of the patients
(without ACS) is almost unchanged, at least in Sweden. It
is therefore reasonable to believe that patients with ACS
now contribute with more than 62 % of the total cost. The
patterns of cost presented here should thus be applicable
to the majority of the patients in 2006, and could be used
for e.g. economic evaluations of new diagnostic methods
for low/moderate risk chest pain patients in the ED.
Comparison with previous studies
Few previous studies describe the cost of consecutive,
unselected ED patients [10,11]. The study most similar to
the present one is by Kontos et al [11] 1994, which reports
the 30 days cost of consecutive ED patients with symp-
toms suggestive of acute cardiac ischemia. In this study,
patients managed with a standard diagnostic strategy cost
Total cost per visit in relation to ED triage to discharge (right  bars) and admission to different hospital units Figure 2
Total cost per visit in relation to ED triage to discharge (right 
bars) and admission to different hospital units. N = number 
of patient visits in each group. Two patients that died in the 
ED are not included.
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an average $6044 (43 kSEK), which is 60 % higher than in
the present study, despite a shorter length of stay (3 vs 5
days) and a lower proportion of MI's (10 vs 13%). On the
other hand, the cost of patients without ACS admitted one
day or less (7.6 kSEK) in the present study is comparable
to the cost of non-chest pain unit care (7.1 kSEK) for
patients without ACS in a UK study [4]. The cost for chest
pain unit (CPU) care for similar patients in the US has
been higher; $1–$9 k, or 7–64 kSEK [7-9,21]. Further, our
ACS patients (79.9 kSEK) cost somewhat more than AMI
patients in Europe (51–70 kSEK [22,23]), but somewhat
less than low risk AMI patients in the USA ($10–13.5 k, or
86–95 kSEK [6,7]). Possible explanations for these differ-
ences include different cost sampling periods, reimburse-
ment systems, triage routines and resource utilization
patterns.
Cost effectiveness
Our practice to admit 67% of the ED chest pain patients,
with 31 % of the admitted having an ACS, was crudely
estimated to result in a cost of about 350 kSEK (equalling
approximately 38 kEUR) per life-year saved compared to
a theoretical strategy of discharging all patients home
from the ED. According to the Swedish National Board of
Health and Welfare, this is regarded a cost-effective prac-
tice (< 500 kSEK per life-year saved). Our results are thus
consistent with the simulation model of Wears et al.
which indicated that an AMI rate of 20–30% or more
among the admitted patients is cost-effective[5]. In the
present study, the number of additional life-years saved
was crudely estimated from the in-hospital reduction in
mortality only in ACS patients, and not in patients with
other diagnoses.
Our assumption that mortality would be twice as high if
ACS patients were discharged from the ED is based on two
US studies from 1977–85[15] and 1993[16] which report
the 3 day and 30 day mortality, respectively. The patients
included in the study by Pope et al[16], were slightly dif-
ferent from our patients; they were on average 3–4 years
younger and more had diabetes (21%), and this of course
influences the validity of our assumption and the accuracy
of our estimation of the cost of life-years saved. Further,
the 95 percent confidence interval of the 2-fold mortality
increase reported by Pope et al. was broad, 0.7 to 5.2. In
the study by Lee et al, comparable patient characteristics
and a confidence interval are not given. As the above stud-
ies only looked at short term mortality and were per-
formed before modern reperfusion therapy such as PCI
and secondary prophylactics, the true cost of a life-year
saved by hospitalization in the present study may well be
lower than our estimation.
Our current practice thus seems to be cost-effective over-
all, but the large overadmission indicates that there is still
a great potential for cost savings and improved quality of
care with improved diagnostic strategies in the ED. Also, it
is likely that there are subgroups for which our admission
routines would not be considered economically effective.
For instance, for chest pain patients presenting with a nor-
mal ECG, the cost for a life-year saved has been estimated
to be $ 1.7 million [6].
Implications for improvement of patient management
From Figure 1 it is clear that efforts to decrease costs for
suspected ACS patients should primarily be aimed at
reducing the length of hospital stay. This is well in line
with the current movement towards dedicated CPUs, with
rapid rule-out diagnostic protocols. Randomized control-
led trials on the value of these CPUs are few but indicate
that they can introduce more effective patient evaluation
with outcomes similar to that in traditional EDs. Cost sav-
ings have been reported per evaluated patient [4], but not
yet at the hospital level.
It seems that the ideal diagnostic strategy, however, is one
performed immediately in the ED, without the need for
CPU or hospital admission. In the future, it may well be
that modern conventional ED management supple-
mented by risk prediction algorithms, blood samples for
new cardiac markers and/or selected investigations such
as myocardial perfusion imaging [11], computerized tom-
ography or magnetic resonance imaging will decrease or
even eliminate the benefits of establishing dedicated chest
pain units.
Potential cost reductions with new ED evaluation 
strategies
Physicians often have multiple reasons for admitting the
patient, and it has been estimated that even with perfect
diagnostics in the ED, only some 40% of the now admit-
ted patients without ACS could be immediately dis-
charged from the ED [1]. In the present study 37% (n =
244) of the admitted patients without ACS were hospital-
ized for one day or less. We assume that this is the group
of patients that could, with improved diagnostics in the
future, be directly discharged from the ED. For each such
patient discharged, some 6 kSEK could be saved (Results),
if extra costs from improved diagnostics are small.
Improved decision-making in the ED could not only
reduce the number of patients admitted without ACS but
also reduce the number of patients admitted to a higher
level of care than needed. Since 40% of patients admitted
to the CCU and 77% of the patients admitted to the ICW
did not have ACS, there seems to be a potential for more
appropriate utilization of these units and large cost sav-
ings. Admitting a patient to the ICW instead of the CCU,
or to the GW instead of the ICW would crudely halve the
cost per admission day. Several studies have shown thatBMC Emergency Medicine 2006, 6:6 http://www.biomedcentral.com/1471-227X/6/6
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the fraction of low and moderate risk patients admitted to
non-intensive care units can safely be increased with mod-
ern risk prediction algorithms [24].
Study limitations
Our data were retrospective and collected from July to
November at only one ED in Sweden, which limit the gen-
eral applicability of our results. For instance, seasonal var-
iation in patient flow may exist. Only direct hospital costs
were analyzed, which prevents any conclusion regarding
the total health care or society costs for these patients. The
cost of pharmaceuticals was included in the cost of admis-
sion days as a fixed percentage. The true cost of pharma-
ceuticals in different subgroups of patients can and does
vary. The results of the cost-effectiveness analysis did not
take into account the potential uncertainty in the param-
eters used, due to sampling variability and the assump-
tions used.
Conclusion
The present results indicate that chest pain patients con-
tribute with a high direct cost to our health care system.
Our current admission practice seems to be overall cost
effective. There is however still a large potential for cost
savings. Almost 40% of the total cost was spent on
patients not having an ACS, with admission time account-
ing for about 2/3 of the total cost for these patients. Efforts
to reduce cost should be aimed at minimizing admissions
for patients without ACS via improved ED diagnostics,
and/or at reducing length of stay. Methods to safely
reduce of the number of non-ACS patients admitted to the
CCU could add further cost savings.
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